Arata Azuma
Nippon Medical School
2 papers in the Anchorcite directory, published between 2014 and 2018, cited 8,976 times in total.
ORCID profileResearch topics
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis · 2 papers
- Chronic Obstructive Pulmonary Disease (COPD) Research · 1 paper
- Pulmonary Hypertension Research and Treatments · 1 paper
- Occupational and environmental lung diseases · 1 paper
- Medical Imaging and Pathology Studies · 1 paper
Frequent co-authors
- Luca Richeldi · 2 papers
- Ganesh Raghu · 2 papers
- Kevin M. Brown · 2 papers
- Vincent Cottin · 2 papers
- Yoshikazu Inoue · 2 papers
- Andrew Gordon Nicholson · 2 papers
- Moisés Selman · 2 papers
- Harold R. Collard · 2 papers
Papers
- Efficacy and Safety of Nintedanib in Idiopathic Pulmonary FibrosisNew England Journal of Medicine · 2014 · 4,771 citations
BACKGROUND: Nintedanib (formerly known as BIBF 1120) is an intracellular inhibitor that targets multiple tyrosine kinases. A phase 2 trial suggested that treatment with 150 mg of nintedanib twice daily reduced lung-function decline and acute exacerbations in patients with idiopathic…
- Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice GuidelineAmerican Journal of Respiratory and Critical Care Medicine · 2018 · 4,205 citations
BACKGROUND: This document provides clinical recommendations for the diagnosis of idiopathic pulmonary fibrosis (IPF). It represents a collaborative effort between the American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and Latin American Thoracic Society. METHODS: The evidence syntheses were…
Metadata from OpenAlex (CC0).